Concurrent cisplatin and radiotherapy in advanced head and neck cancer

被引：4
|
作者：
Rehan Asif
Kamlesh Chandra
Vanita Chopra
M. L. B. Bhatt
机构：
[1] Deptt of Otorhmolaryngology,Deptt of Radiotherapy
[2] J N M C Hospital,undefined
[3] A.M U,undefined
来源：
Indian Journal of Otolaryngology and Head and Neck Surgery | 2003年 / 55卷 / 2期
关键词：
Neck Cancer; Bleomycin; Local Tumor Control; Local Tumor Recurrence; Concomitant Chemotherapy;
D O I：
10.1007/BF02974612
中图分类号：
学科分类号：
摘要：
Management of Head and Neck Cancers poses a challenge inspite of several advances because of poor success in terms of response rate, survival and reduced morbidity of the patients. In the present study 30 untreated histologically proven cases of head and neck cancers were subjected to weekly radiotherapy with adjuvant chemotherapy (cisplatin 30 mg/m2 intravenously). This study group was compared with a group of 30 patients who were given only radiotherapy. Results have shown that combination of chemotherapy with radiotherapy gives a significantly better results in tumour as well as nodal response with minimal toxicities.
引用
收藏
页码：94 / 96
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
    Satoshi Hamauchi
    Tomoya Yokota
    Takatsugu Mizumachi
    Yusuke Onozawa
    Hirofumi Ogawa
    Tsuyoshi Onoe
    Tomoyuki Kamijo
    Yoshiyuki Iida
    Tetsuo Nishimura
    Tetsuro Onitsuka
    Hirofumi Yasui
    Akihiro Homma
    International Journal of Clinical Oncology, 2019, 24 : 468 - 475
  • [32] High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer
    Chang, Chia-Lun
    Yuan, Kevin Sheng-Po
    Wu, Szu-Yuan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (07): : 1364 - 1370
  • [33] Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
    Hamauchi, Satoshi
    Yokota, Tomoya
    Mizumachi, Takatsugu
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Kamijo, Tomoyuki
    Iida, Yoshiyuki
    Nishimura, Tetsuo
    Onitsuka, Tetsuro
    Yasui, Hirofumi
    Homma, Akihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 468 - 475
  • [34] Toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin ineligible head and neck cancer patients.
    Simha, Vijai
    Patil, Vijay Maruti
    Joshi, Amit
    Noronha, Vanita
    Talreja, Vikas
    Dhumal, Sachin
    Chandrasekharan, Arun
    Shrirangwar, Sameer
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Cetuximab, cisplatin and amifostine during accelerated radiotherapy for locally advanced head and neck cancer
    Tsoutsou, P. G.
    Danielidis, V.
    Koukourakis, M. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
    Beckmann, GK
    Hoppe, F
    Pfreundner, L
    Flentje, MP
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (01): : 36 - 43
  • [37] COMBINED RADIOTHERAPY WITH CISPLATIN OR CARBOPLATIN IN ADVANCED HEAD AND NECK TUMORS
    ZAMBOGLOU, N
    PAPE, H
    SCHNABEL, T
    WURM, R
    BANNACH, B
    FURST, G
    SCHMITT, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 1989, 165 (09): : 647 - 651
  • [38] Phase I trial of bortezomib (VELCADE), cisplatin and radiotherapy for advanced head and neck cancer
    Kubicek, G. J.
    Machtay, M.
    Axelrod, R. A.
    Curran, W. J.
    Keane, W. M.
    Anne, R.
    Mallon, G.
    Myers, T.
    Dicker, A. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer
    Zidan, J
    Kuten, A
    Rosenblatt, E
    Robinson, E
    ORAL ONCOLOGY, 1997, 33 (02) : 129 - 135
  • [40] A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC)
    Guan, Jian
    Zhang, Yue
    Li, Qinyang
    Zhang, Yaowei
    Li, Lu
    Chen, Min
    Xiao, Nanjie
    Chen, Longhua
    ONCOTARGET, 2016, 7 (43) : 70185 - 70193
12345